Show simple item record

dc.contributor.authorRCPI Clinical Advisory Group on HCAI & AMR, Subgroup MRSA Guidelines Committee
dc.date.accessioned2013-10-14T09:53:41Z
dc.date.available2013-10-14T09:53:41Z
dc.date.issued2013-04
dc.identifier.urihttp://hdl.handle.net/10147/303381
dc.descriptionMethicillin-resistant Staphylococcus aureus (MRSA) is responsible for about 10% of all the healthcare-associated infections. Some of these infections are life-threatening, e.g. bloodstream infection, and many re sult in considerable patient suffering and morbidity. While there has been a welcome decline in the number of cases of MRSA bloodstream infection in recent years, developments have oc curred since the last set of national guidelines were issued in 2005 and an updated set of guide lines is overdue. A multi-disciplinary team has reviewed the last set of gui delines together with other guidelines published abroad in the interim, as well as the scientific literature, and produced a set of recommendations which reflect best practice and are dr afted to improve the quality of patient care. The group is grateful to all those who provided constructive a nd helpful feedback during the review stage. This set of guidelines wi ll be reviewed again in 2016en_GB
dc.language.isoenen
dc.publisherHealth Protection Surveillance Centre (HPSC)en_GB
dc.subjectCOMMUNICABLE DISEASEen_GB
dc.subjectINFECTION CONTROLen_GB
dc.subject.otherHEALTHCARE-ACQUIRED INFECTIONSen_GB
dc.titleThe control and prevention of MRSAen_GB
dc.typeReporten
refterms.dateFOA2018-08-23T08:26:15Z


Files in this item

Thumbnail
Name:
File12678.pdf
Size:
906.6Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record